AUDREY ALLEN: Open Payments
NPI 1710232947 · NEW LONDON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 10 payments from 5 companies in 2025. Trend: 2023 $554 · 2024 $393 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $113 |
| Janssen Pharmaceuticals, Inc | 1 | $107 |
| Supernus Pharmaceuticals, Inc. | 4 | $83 |
| E.R. Squibb & Sons, L.L.C. | 1 | $43 |
| Corium, LLC | 1 | $34 |
Products named: CAPLYTA, INVEGA SUSTENNA, Qelbree, COBENFY, Azstarys.
Industry payments across CT — which companies pay providers there.
